MEDICAL SIMULATION TRAINING BUSINESS PLAN

I. Executive Summary

Company Description

AcuSim Health (name chosen to reflect accurate simulation of clinical acuity) is based in a major U.S. medical hub and operates in the medical simulation and professional healthcare training sector. The company provides an elite, subscription-based B2B platform combining immersive virtual reality (VR) scenarios with high-fidelity physical patient models to deliver risk-free clinical training. Key offerings include scenario libraries, instructor dashboards, integrated performance analytics, and turnkey hardware-software bundles that replicate real-world procedures with repeatable outcomes. One line: premium, repeatable clinical practice without patient risk.

We deliver training through software development by engineers, scene and model creation by 3D artists, and clinical validation by medical experts, plus on-site integration and ongoing support for hospitals, medical schools, and emergency services. What sets us apart is the fusion of hyper-realistic VR with tactile models, validated clinical content, and a subscription model that simplifies budgeting. Target customers are institutional clinical educators and emergency response trainers. Short-term goal: deploy in 10 pilot institutions within 12 months. Long-term goal: become the standard clinical-skill subscription across 200+ teaching hospitals and 50 emergency services programs within five years. One line: measurable skills improvement at scale for clinical teams.

Problem

Clinicians lack safe, repeatable opportunities to practice high-risk procedures, so theoretical training often fails to produce real-world competence and crisis management skills.

Existing training methods are static and do not reproduce physiological complexity, which contributes to medical errors remaining a leading cause of patient harm and reduces clinician confidence and skill retention.

Hospitals, medical schools, and emergency services have no widely adopted modality that combines immersive realism with controlled failure-and-learning environments, creating a clear need for a risk-free, hyper-realistic simulation solution.

Solution

Elite medical simulation platform that combines immersive virtual reality with high-fidelity physical manikins to give clinicians repeatable, measurable practice of high-risk procedures—so they can practice complex skills safely before the operating room.

Delivers synchronized VR scenarios with tangible haptics, a proprietary scenario library kept current with protocols, team-based crisis simulations, and objective metrics for skill progression and credentialing—reducing the competency gap that leads to preventable medical errors.

Mission Statement

Our mission is to elevate clinical competency and enhance patient safety by providing the world’s most realistic, data-driven medical simulation platform. We bridge the gap between theory and practice through innovation in VR and haptics so every healthcare professional is prepared for high-stakes clinical challenges. We are committed to eliminating preventable medical errors and empowering clinicians with the confidence and skills necessary to save lives.

Key Success Factors

Critical operational and financial milestones that must be met to achieve projected scale and stakeholder validation.

• Reach 85% occupancy by 2030 to maximize revenue and platform impact.
• Maintain hyper-realism through continuous R&D and medical expert collaboration.
• Secure 12,200 training seats across subscription tiers to meet demand forecasts.
• Manage $415,000 CapEx to ensure high-quality hardware availability at launch.
• Achieve Year 1 EBITDA $53,015,000 to validate the business model to stakeholders.

Financial Summary

The Financial Summary presents key metrics at launch and the first three forecast years for the Medical Simulation Training business.

Financial requirements: Minimum cash of $1,729,000 required at launch (Jan-26). Payback occurs in one month; breakeven in Jan-26. Internal Rate of Return is 0% and Return on Equity is 16,970.35%.

Overall outlook: exceptional early profitability with rapid payback and strong equity returns.

Funding Requirements

We require capital to acquire equipment, complete product finalization, and fund launch operations to reach breakeven in January 2026.

Financial snapshot: Year 1 EBITDA $53,015,000; Year 5 EBITDA $9,021,314,000; breakeven January 2026 with a one-month payback; subscription tiers Basic $50–$70, Pro $150–$190, Enterprise $400–$500; occupancy scales 40% to 85%; ROE 16,970.35.